sinc
emerg
novel
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
first
report
wuhan
china
neither
specif
vaccin
antivir
drug
becom
avail
howev
combin
two
proteas
inhibitor
lopinavir
ritonavir
found
effect
sarscov
drug
could
bind
well
sarscov
proteas
sarscov
pro
work
molecular
complex
inhibitor
pro
studi
use
allatom
molecular
dynam
simul
free
energi
calcul
pair
interact
energi
analys
base
mmpb
gb
sa
method
antihiv
drug
interact
well
residu
activ
site
pro
ritonavir
show
somewhat
higher
number
atom
contact
somewhat
higher
bind
effici
somewhat
higher
number
key
bind
residu
compar
lopinavir
correspond
slightli
lower
water
access
pro
activ
site
addit
ritonavir
could
interact
oxyanion
hole
residu
via
format
two
hydrogen
bond
interact
term
electrostat
dispers
charg
transfer
play
import
role
drug
bind
obtain
result
demonstr
repurpos
antihiv
drug
could
use
combat
n
decemb
mani
case
patient
report
respiratori
tract
infect
sever
pneumonia
wuhan
china
found
patient
like
epidemiolog
histori
relat
seafood
market
area
china
howev
newli
caus
microbi
infect
first
identifi
public
databas
basi
whole
genom
sequenc
reveal
microbi
pathogen
novel
coronaviru
formal
name
close
relat
bat
sever
acut
respiratori
syndrom
sar
like
coronaviru
socal
world
health
organ
offici
confirm
outbreak
decemb
eventu
offici
name
coronaviru
diseas
gener
coronavirus
character
envelop
positivesens
singlestrand
rna
virus
genu
coronaviru
famili
coronavirida
infect
human
sever
anim
includ
mammal
bird
nonetheless
coronavirus
potenti
caus
sever
infect
patient
wellknown
outbreak
sarscov
guangdong
china
middl
east
respiratori
syndrom
coronaviru
merscov
mani
countri
middl
east
likewis
confirm
transmit
human
human
quickli
spread
sever
countri
throughout
world
betacoronaviru
like
sarscov
merscov
origin
bat
clinic
symptom
infect
culmin
fatal
pneumonia
clinic
present
greatli
resembl
sarscov
infect
patient
infect
might
also
develop
acut
respiratori
distress
syndrom
lead
high
rate
admiss
intens
care
unit
ultim
death
sever
case
infect
patient
present
mild
sever
symptom
includ
fever
cough
sore
throat
rhinorrhea
sever
pneumonia
septic
shock
date
mani
compani
academ
research
group
around
world
focus
search
develop
specif
vaccin
antivir
drug
prevent
control
emerg
infect
eg
vaccin
monoclon
antibodi
smallmolecul
drug
howev
option
need
sever
month
year
develop
urgent
need
allevi
pandem
use
repurpos
exist
antivir
drug
approv
treatment
viral
infect
human
immunodefici
viru
hiv
hepat
b
viru
hepat
c
viru
influenza
somewhat
promis
base
previou
success
therapeut
treatment
two
relev
human
coronavirus
sarscov
merscov
accord
numer
previou
studi
nonstructur
protein
coronaviru
particular
main
proteas
proteas
pro
consid
attract
drug
target
treatment
coronaviru
infect
role
proteas
involv
proteolyt
process
replicas
polyprotein
crucial
viral
replic
matur
moreov
pro
similar
common
cleavag
site
among
coronavirus
sequenc
align
pro
see
figur
show
proteinas
highli
conserv
compar
sarscov
sequenc
ident
combin
two
approv
drug
hiv
infect
lopinavir
ritonavir
kaletra
report
activ
toward
sar
mer
antihiv
drug
initi
purpos
inhibit
pro
sarscov
merscov
appear
relat
clinic
benefit
patient
sar
nonrandom
openlabel
trial
although
ritonavir
proteas
inhibitor
gener
use
inhibit
cytochrom
markedli
increas
plasma
concentr
proteas
inhibitor
nevertheless
whether
hiv
proteas
inhibitor
could
effect
target
pro
debat
base
fact
hiv
proteas
aspart
proteas
famili
wherea
pro
belong
cystein
proteas
famili
previous
theoret
studi
molecular
interact
lopinavir
ritonavir
pro
sarscov
suggest
two
drug
could
bind
well
substratebind
pocket
sarscov
pro
date
threedimension
structur
pro
complex
lopinavir
ritonavir
report
thu
studi
aim
investig
bind
interact
lopinavir
ritonavir
proteinas
use
molecular
model
quantum
chemic
method
hope
inform
use
futur
design
develop
specif
inhibitor
treatment
human
coronavirus
biochemistri
pubsacsorgbiochemistri
articl
lopinavir
ritonavir
bound
protom
posit
origin
peptidelik
inhibitor
chang
correspond
drug
p
posit
figur
c
modif
perform
accord
similar
orient
templat
inhibitor
use
small
molecul
tool
implement
accelri
discoveri
studio
accelri
inc
proton
state
ioniz
amino
acid
assign
ph
use
h
web
server
except
catalyt
residu
set
neutral
form
proton
delta
posit
hid
type
amber
format
accord
common
reaction
mechan
cystein
proteas
chemic
structur
lopinavir
ritonavir
download
databas
electrostat
potenti
esp
charg
ligand
calcul
level
theori
use
program
antechamb
parmchk
modul
use
gener
restrain
esp
charg
miss
paramet
two
drug
respect
bond
nonbond
paramet
protein
ligand
treat
amber
forc
field
gener
amber
forc
field
version
accordingli
miss
hydrogen
atom
ad
use
leap
modul
implement
afterward
water
model
use
solvat
system
minimum
distanc
protein
surfac
solvat
box
edg
box
dimens
set
approxim
sodium
ion
randomli
ad
neutral
simul
system
ad
hydrogen
atom
water
molecul
minim
use
step
steepest
descent
sd
follow
step
conjug
gradient
cg
method
run
md
simul
rest
molecul
held
fix
protein
ligand
minim
sd
iter
cg
iter
method
constrain
solvent
molecul
final
whole
complex
fulli
minim
use
procedur
molecular
dynam
simul
system
simul
period
boundari
condit
npt
scheme
previous
describ
briefli
cutoff
distanc
nonbond
interact
set
particl
mesh
ewald
summat
method
employ
treat
electrostat
interact
shake
algorithm
use
constrain
coval
bond
involv
hydrogen
atom
fs
simul
time
step
use
throughout
md
simul
temperatur
pressur
control
langevin
thermostat
collis
frequenc
ps
berendsen
barostat
pressurerelax
time
ps
heat
step
simul
system
gradual
heat
k
ps
harmon
posit
restraint
kcal
mol
appli
atom
protein
equilibr
system
complex
subject
four
step
restrain
md
simul
k
harmon
restraint
kcal
mol
ps
total
anoth
ps
without
restraint
subsequ
entir
system
simul
npt
ensembl
k
atm
reach
ns
md
trajectori
save
everi
ps
calcul
term
rootmeansquar
displac
rmsd
number
hydrogen
bond
hbond
number
atom
contact
atom
contact
drug
molecul
use
verifi
stabil
investig
model
well
structur
featur
complex
hbond
interact
calcul
use
two
criteria
distanc
hydrogen
donor
hd
acceptor
ha
ii
angl
atom
contact
count
number
pro
atom
within
drug
evalu
bind
affin
key
bind
residu
involv
ligand
bind
complex
total
bind
free
energi
bind
perresidu
decomposit
free
energi
bind
residu
calcul
base
molecular
gener
born
surfac
area
mmpb
gb
sa
method
perform
md
snapshot
extract
last
ns
md
product
phase
note
interact
bind
free
energi
carri
use
cpptraj
mmpbsapi
modul
respect
furthermor
intermolecular
interact
drug
bind
residu
atom
level
describ
pair
interact
energi
decomposit
analysi
pieda
base
fragment
molecular
orbit
fmo
method
secondord
perturb
energi
level
theori
use
gamess
solvat
effect
also
treat
polariz
continuum
model
pcm
higher
lopinavir
model
hbond
atom
contact
suggest
ritonavir
suscept
pro
discuss
detail
work
md
trajectori
ns
thu
extract
analysi
term
bind
affin
lopinavir
ritonavir
pro
ii
key
bind
residu
involv
drug
bind
iii
hbond
iv
water
access
enzym
activ
site
biochemistri
pubsacsorgbiochemistri
articl
predict
inhibitori
effici
suscept
lopinavir
ritonavir
pro
estim
use
mmpb
gb
sa
approach
snapshot
extract
last
ns
simul
note
mmpbsa
mmgbsa
result
tabl
provid
similar
trend
bind
free
energi
predict
accord
molecular
mechan
mm
calcul
found
van
der
waal
vdw
interact
main
forc
induc
molecular
complex
pro
lopinavir
vdw
kcalmol
ritonavir
kcalmol
stronger
electrostat
attract
ele
valu
kcalmol
respect
find
good
agreement
mm
result
two
antihiv
drug
complex
sarscov
ii
darunavir
amprenavir
bind
proteas
taken
togeth
solvat
effect
entrop
term
bind
affin
bind
ritonavir
pro
kcalmol
taken
mmpbsa
mmgbsa
method
respect
rel
higher
anoth
drug
kcalmol
respect
predict
result
suggest
key
residu
repurpos
hiv
drug
combat
evalu
key
residu
involv
antihiv
drug
bind
activ
site
pro
bind
residu
calcul
base
mmgbsa
method
perform
total
energi
contribut
residu
associ
drug
bind
complex
plot
figur
drug
orient
enzym
activ
site
illustr
right
panel
contribut
amino
acid
color
accord
bind
residu
valu
import
note
residu
exhibit
energi
stabil
kcalmol
taken
account
obtain
result
reveal
four
nine
residu
import
bind
lopinavir
ritonavir
respect
strongli
contribut
residu
found
pro
complex
accord
result
mention
figur
tabl
similarli
report
sarscov
pro
residu
ii
strongli
stabil
quinazolinecontain
compound
mainli
hydrophob
interact
hbond
format
respect
line
find
bind
residu
calcul
show
phenyl
ring
posit
lopinavir
thiazol
ring
posit
ritonavir
insert
pocket
pro
form
hydrophob
contact
residu
figur
atom
ritonavir
stabil
nh
group
via
hbond
format
figur
discuss
note
ritonavir
could
interact
catalyt
residu
oxyanion
hole
residu
bind
residu
kcalmol
residu
suggest
molecular
structur
ritonavir
fit
well
within
activ
site
pro
obtain
inform
support
wellalign
structur
ritonavir
last
ns
simul
figur
wherea
larg
fluctuat
site
detect
lopinavir
term
contribut
electrostat
ele
polar
black
line
vdw
vdw
nonpolar
red
line
energi
residu
seen
figur
main
energi
contribut
stabil
proteas
inhibitor
lopinavir
ritonavir
vdw
energi
kcalmol
especi
residu
wherea
electrostat
contribut
observ
rang
approxim
kcalmol
relat
mm
calcul
see
tabl
howev
common
concern
drawback
molecular
mechan
calcul
particular
electron
properti
calcul
addit
perform
last
snapshot
complex
investig
interact
enzym
activ
site
advantag
method
known
includ
electron
correl
trustworthili
describ
hydrophob
effect
hydrogen
bond
interact
ligand
individu
residu
figur
highlight
biochemistri
pubsacsorgbiochemistri
articl
ritonavir
bind
energi
stabil
approxim
kcalmol
wherea
residu
show
less
energi
stabil
approxim
kcalmol
like
dispers
electrostat
interact
except
residu
impact
solvat
effect
predominantli
found
two
drug
bind
pro
compar
recent
report
potent
inhibitor
bound
pro
antihiv
drug
lopinavir
ritonavir
lack
moieti
ii
group
locat
posit
iii
polar
moieti
phenyl
ring
region
howev
phenyl
ring
site
proteas
inhibitor
remain
larger
hydrophil
found
proteas
inhibitor
region
lopinavir
ritonavir
strongli
interact
pro
pocket
respect
figur
accordingli
basi
evid
propos
ration
design
novel
proteas
inhibitor
deriv
lopinavir
ritonavir
enhanc
bind
effici
pro
follow
chang
phenyl
ring
region
ring
increas
extent
hbond
format
residu
ii
introduc
polar
moieti
eg
pyridon
ring
form
hbond
neg
charg
iii
ad
reactiv
group
locat
posit
coval
bond
catalyt
residu
depict
figur
hydrogen
bond
although
interact
primarili
contribut
vdw
interact
format
hbond
antihiv
drug
surround
residu
activ
site
pro
could
import
factor
inhibit
target
enzym
monitor
interact
percentag
hbond
occup
plot
figur
wherea
repres
structur
determin
last
md
snapshot
depict
figur
expect
hbond
format
three
four
hbond
drug
surround
residu
insid
activ
site
pro
observ
case
lopinavir
three
hbond
notic
import
residu
also
agre
well
report
bind
proteas
inhibitor
sarscov
notabl
ritonavir
show
slightli
higher
level
hbond
format
pro
site
stabil
oxyanion
hole
residu
solvent
access
pro
activ
site
activ
site
pro
locat
near
solventexpos
area
water
molecul
might
play
role
stabil
interact
character
effect
water
access
pro
activ
site
solventaccess
surfac
area
sasa
figur
calcul
perform
residu
within
antihiv
drug
moreov
radial
distribut
function
rdf
figur
water
oxygen
toward
heteroatom
lopinavir
ritonavir
use
verifi
number
water
molecul
approach
ligand
complex
model
pro
homodim
contain
antihiv
drug
bind
protom
seen
figur
sasa
protom
b
blue
lopinavir
ritonavir
system
respect
upon
molecular
complex
protom
yellow
sasa
lopinavir
ritonavir
system
dramat
decreas
manner
similar
studi
consid
rdf
result
found
first
peak
lopinavir
system
slightli
higher
ritonavir
system
indic
access
water
molecul
pronounc
pro
complex
hbond
water
network
also
play
role
stabil
complex
investig
hbond
water
bridg
around
heteroatom
ligand
use
structur
criteria
hbond
describ
elsewher
obtain
result
demonstr
one
bridg
water
coordin
lopinavir
well
ii
ritonavir
low
percentag
occup
suggest
bridg
water
make
signific
contribut
mediat
hbond
network
bind
work
bind
pattern
suscept
two
proteas
inhibitor
lopinavir
ritonavir
complex
pro
fulli
reveal
allatom
md
simul
bind
free
energi
estim
pieda
base
mmpb
gb
sa
calcul
respect
accord
bind
predict
suscept
pro
ritonavir
somewhat
higher
lopinavir
support
energi
stabil
individu
residu
result
method
mmgbsa
lopinavir
mmgbsa
ritonavir
ii
lopinavir
ritonavir
addit
oxyanion
hole
residu
found
interact
ritonavir
via
hydrogen
bond
data
electrostat
dispers
charg
transfer
consid
import
interact
drug
bind
obtain
result
demonstr
repurpos
antihiv
drug
could
use
combat
fundament
knowledg
atom
level
could
also
help
design
develop
specif
inhibitor
treat
human
coronavirus
support
inform
avail
free
charg
http
amino
acid
sequenc
structur
comparison
pdf
